Keyphrases
Acute Ischemic Stroke
21%
Acute Stroke
32%
Adjusted Odds Ratio
7%
Antiplatelet
8%
Antiplatelet Therapy
12%
Aspirin
8%
Atrial Fibrillation
13%
Clinical Outcomes
8%
Computed Tomography
6%
Confidence Interval
13%
COVID-19
7%
Denmark
13%
Disability-adjusted Life Years
10%
European Stroke Organisation
9%
Functional Outcome
11%
Global Burden
9%
Global Burden of Disease Study
23%
Glyceryl Trinitrate
11%
Hematoma Expansion
12%
Hyperacute
7%
Intracerebral Hemorrhage
35%
Intravenous Thrombolysis
7%
Ischemic Stroke
37%
Magnetic Resonance Imaging
7%
Modified Rankin Scale
15%
National Burden
7%
National Institutes of Health Stroke Scale (NIHSS)
7%
Nitric Oxide
15%
Odds Ratio
9%
Oral Anticoagulants
9%
Paroxysmal Atrial Fibrillation
8%
Placebo
6%
Prospective Cohort Study
7%
Randomized Controlled Trial
25%
Regional Burden
7%
Risk Factors
10%
Small Vessel Disease
9%
Socio-demographic Index
8%
Spontaneous Intracerebral Hemorrhage
24%
Spot Sign
8%
Stroke Burden
6%
Stroke Ischemic
13%
Stroke Patients
13%
Stroke Trials
18%
Thrombolysis
10%
Thrombolytic Therapy
6%
Tranexamic Acid
19%
Transient Ischemic Attack
22%
Uncertainty Interval
8%
Wake-up
7%
Medicine and Dentistry
Acetylsalicylic Acid
6%
Antiplatelet
10%
Antithrombotic
8%
Apoplexy
100%
Atrial Fibrillation
13%
Bleeding
9%
Blood Clot Lysis
11%
Blood Pressure
8%
Brain Ischemia
48%
Cerebral Hemorrhage
42%
Cerebrovascular Disease
5%
Computed Tomography Angiography
8%
Computer Assisted Tomography
9%
COVID-19
7%
Disability Adjusted Life Years
8%
Disease
9%
Global Disease Burden
23%
Glyceryl Trinitrate
10%
Hematoma
14%
Infarction
6%
Injury
9%
Life Expectancy
8%
Magnetic Resonance Imaging
11%
Modified Rankin Scale
11%
Mortality Rate
5%
National Institutes of Health Stroke Scale
6%
Nitric Oxide
14%
Odds Ratio
14%
Paroxysmal Atrial Fibrillation
8%
Placebo
11%
Prevalence
6%
Prospective Cohort Study
7%
Randomized Controlled Trial
20%
Small Vessel Disease
5%
Subgroup Analysis
6%
Symptom
8%
Systematic Review
8%
Tranexamic Acid
11%
Transient Ischemic Attack
21%
Vitamin K Antagonist
5%